BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jonaitis L, Pellicano R, Kupcinskas L. Helicobacter pylori and nonmalignant upper gastrointestinal diseases. Helicobacter. 2018;23 Suppl 1:e12522. [PMID: 30203583 DOI: 10.1111/hel.12522] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Choi YI, Jeong SH, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, So S, Lee JH, Jeong JY, Lee SM. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea. Can J Infect Dis Med Microbiol. 2019;2019:9351801. [PMID: 31360270 DOI: 10.1155/2019/9351801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Gong Y, Kang J, Wu R, Ge F, Zheng YS, Zeng Q. Gastroscopic results for the asymptomatic, average-risk population in Northern China: a cross-sectional study of 60,519 adults. Scand J Gastroenterol 2022;:1-9. [PMID: 35132926 DOI: 10.1080/00365521.2022.2035810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Schnedl WJ, Enko D. Considering histamine in functional gastrointestinal disorders. Crit Rev Food Sci Nutr 2020;:1-8. [PMID: 32643952 DOI: 10.1080/10408398.2020.1791049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Mosso E, Bonetto S, Longobardi G, Abenavoli L, Ribaldone DG, Saracco GM, Pellicano R. Management of functional dyspepsia in 2020: a clinical point of view. Minerva Gastroenterol Dietol 2020;66:331-42. [PMID: 32623872 DOI: 10.23736/S1121-421X.20.02732-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Smith S, Fowora M, Pellicano R. Infections with Helicobacter pylori and challenges encountered in Africa. World J Gastroenterol 2019; 25(25): 3183-3195 [PMID: 31333310 DOI: 10.3748/wjg.v25.i25.3183] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
6 Spiegelhauer MR, Kupcinskas J, Johannesen TB, Urba M, Skieceviciene J, Jonaitis L, Frandsen TH, Kupcinskas L, Fuursted K, Andersen LP. Transient and Persistent Gastric Microbiome: Adherence of Bacteria in Gastric Cancer and Dyspeptic Patient Biopsies after Washing.J Clin Med. 2020;9. [PMID: 32560179 DOI: 10.3390/jcm9061882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Mladenova I. Helicobacter pylori and cardiovascular disease: update 2019. Minerva Cardioangiol 2019;67:425-32. [PMID: 31343146 DOI: 10.23736/S0026-4725.19.04986-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jonaityte IR, Ciupkeviciene E, Jonaitis P, Kupcinskas J, Petkeviciene J, Jonaitis L. Changes in the Seroprevalence of Helicobacter pylori among the Lithuanian Medical Students over the Last 25 Years and Its Relation to Dyspeptic Symptoms. Medicina (Kaunas) 2021;57:254. [PMID: 33803389 DOI: 10.3390/medicina57030254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Valizadeh Toosi SM, Yaghobi M, Mohammad Pour RA. Prevalence of Helicobacter Pylori Infection in Patients with Dyspepsia in North of Iran. Middle East J Dig Dis 2021;13:230-6. [DOI: 10.34172/mejdd.2021.230] [Reference Citation Analysis]
10 Isaeva G, Isaeva R. Molecular methods for the detection of Helicobacter pylori. Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02665-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Valenzano M, Bisio A, Grassi G. Helicobacter pylori and diabetes mellitus: a controversial relationship. Minerva Endocrinol 2019;44:301-9. [PMID: 31304727 DOI: 10.23736/S0391-1977.19.03021-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Isaeva GS. Pangenomic studies of Helicobacter pylori: a key to understanding pathogenesis and human history. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02564-3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu S, Li K, Wang Z, Deng B, Deng C, Lou Y, Jia L. The relationship between abnormal tongue features and non-malignant upper gastrointestinal disorders: A hospital-based cross-sectional study. European Journal of Integrative Medicine 2021;47:101379. [DOI: 10.1016/j.eujim.2021.101379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Krzyżek P, Migdał P, Paluch E, Karwańska M, Wieliczko A, Gościniak G. Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori. Int J Mol Sci 2021;22:2695. [PMID: 33800082 DOI: 10.3390/ijms22052695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751 [PMID: 31857776 DOI: 10.3748/wjg.v25.i46.6743] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
16 Jonaitis P, Kupcinskas J, Nyssen OP, Puig I, Gisbert JP, Jonaitis L. Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg). Medicina (Kaunas) 2021;57:642. [PMID: 34201428 DOI: 10.3390/medicina57070642] [Reference Citation Analysis]
17 Jonaitis P, Kupcinskas L, Kupcinskas J. Molecular Alterations in Gastric Intestinal Metaplasia. Int J Mol Sci 2021;22:5758. [PMID: 34071181 DOI: 10.3390/ijms22115758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zizzi CF, Pellicano R, Biancone L. The relationship between Helicobacter pylori and chronic kidney disease: update 2020. Minerva Gastroenterol Dietol 2020;66:343-9. [PMID: 32623870 DOI: 10.23736/S1121-421X.20.02729-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Marinoni C, Ribaldone DG, Rosso C, Astegiano M, Caviglia GP. Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02555-2] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Niknam R, Lankarani KB, Moghadami M, Taghavi SA, Zahiri L, Fallahi MJ. The association between helicobacter pylori infection and erosive gastroesophageal reflux disease; a cross-sectional study. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07278-6] [Reference Citation Analysis]
21 Schol J, Carbone F, Holvoet L, Van den Houte K, Colomier E, Huang I, Scarpellini E, Vanuytsel T, Tack J. Postinfectious onset in functional dyspepsia is a risk factor for weight loss. J Gastroenterol. [DOI: 10.1007/s00535-022-01854-y] [Reference Citation Analysis]
22 Haddadi MH, Negahdari B, Asadolahi R, Bazargani A. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgrad Med 2020;132:512-20. [PMID: 32281451 DOI: 10.1080/00325481.2020.1753406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Niu Q, Zhu J, Yu X, Feng T, Ji H, Li Y, Zhang W, Hu B. Immune Response in H. pylori-Associated Gastritis and Gastric Cancer. Gastroenterol Res Pract. 2020;2020:9342563. [PMID: 32411209 DOI: 10.1155/2020/9342563] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
24 Kuo CJ, Chen CW, Le PH, Hsu JT, Lin CY, Cheng HT, Su MY, Lin CJ, Chiu CT. Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections. Therap Adv Gastroenterol 2019;12:1756284819870960. [PMID: 31523277 DOI: 10.1177/1756284819870960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Alsohaibani F, Alquaiz M, Alkahtani K, Alashgar H, Peedikayil M, AlFadda A, Almadi M. Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia. Saudi J Gastroenterol 2020;26:84-8. [PMID: 32295933 DOI: 10.4103/sjg.SJG_626_19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Imkamp F, Lauener FN, Pohl D, Lehours P, Vale FF, Jehanne Q, Zbinden R, Keller PM, Wagner K. Rapid Characterization of Virulence Determinants in Helicobacter pylori Isolated from Non-Atrophic Gastritis Patients by Next-Generation Sequencing. J Clin Med. 2019;8. [PMID: 31336977 DOI: 10.3390/jcm8071030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
27 Smith SI, Jolaiya T, Fowora M, Ugiagbe R, Onyekwere C, Agbo I, Lesi O, Palamides P, Adedeji A, Ndububa D, Adekanle O, Adeleye I, Bamidele M, Ngoka F, Ayodeji I, Njom H, Pellicano R. Comparison of polymerase chain reaction-based genotyping of Helicobacter pylori by direct polymerase chain reaction from biopsies and cultures from patients with dyspepsia in Nigeria. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02558-8] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Liu R, Liu Q, He Y, Shi W, Xu Q, Yuan Q, Lin Q, Li B, Ye L, Min Y, Zhu P, Shao Y. Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis. Medicine (Baltimore). 2019;98:e17781. [PMID: 31689846 DOI: 10.1097/md.0000000000017781] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]